REVIEW ARTICLE
Year : 2023 | Volume
: 13 | Issue : 1 | Page : 13--20
Descemet membrane endothelial keratoplasty in eyes with glaucoma
Bryan Le1, Clemence Bonnet2, Madeline Yung4, Sophie X Deng4
1 Stein Eye Institute, Department of Ophthalmology, David Geffen School of Medicine, University of California, Los Angeles, CA; College of Medicine, Drexel University, Philadelphia, Pennsylvania, USA
2 Stein Eye Institute, Department of Ophthalmology, David Geffen School of Medicine, University of California, Los Angeles, CA, USA; Cornea Department, Cochin Hospital, Paris Cité Université, Paris, France
Correspondence Address:
Prof. Sophie X Deng
Stein Eye Institute, University of California, Los Angeles, 200 Stein Plaza, Los Angeles, CA 90095
USA
Endothelial keratoplasty has become the standard for the treatment of endothelial dysfunction. In Descemet membrane endothelial keratoplasty (DMEK), only the endothelium and Descemet membrane are transplanted, providing superior outcomes compared to Descemet stripping endothelial keratoplasty (DSEK). A substantial subset of patients who require DMEK have comorbid glaucoma. Even in eyes with complex anterior segment such as eyes with previous trabeculectomy or tube shunts, DMEK can restore meaningful vision and outperforms DSEK in terms of visual recovery, decreased rejection rate, and the need for high dose of topical steroids. However, accelerated endothelial cell loss and secondary graft failure have been described in eyes with previous glaucoma surgery, namely trabeculectomy and drainage device. During DMEK and DSEK procedures, raised intraocular pressure is required to attach the graft, which could worsen preexisting glaucoma or cause de novo glaucoma. Mechanisms of postoperative ocular hypertension include delayed air clearance, pupillary block, steroid response, and damage to angle structures. Medically treated glaucoma has increased risk for postoperative ocular hypertension. By understanding these additional complications and making appropriate modifications in surgical techniques and postoperative management, DMEK can be performed successfully and achieve very good visual outcome in eyes with glaucoma. Such modifications include precisely controlled unfolding technique, iridectomies that can help avoid pupillary block, tube shunts that can be trimmed to facilitate graft unfolding, air fill tension that can be adjusted, and postoperative steroid regimens that can be modified to decrease the risk for steroid response. Long-term survival of the DMEK graft, however, is shorter in eyes with previous glaucoma surgery than those without, as observed after other types of keratoplasty.
How to cite this article:
Le B, Bonnet C, Yung M, Deng SX. Descemet membrane endothelial keratoplasty in eyes with glaucoma.Taiwan J Ophthalmol 2023;13:13-20
|
How to cite this URL:
Le B, Bonnet C, Yung M, Deng SX. Descemet membrane endothelial keratoplasty in eyes with glaucoma. Taiwan J Ophthalmol [serial online] 2023 [cited 2023 Mar 25 ];13:13-20
Available from: https://www.e-tjo.org/article.asp?issn=2211-5056;year=2023;volume=13;issue=1;spage=13;epage=20;aulast=Le;type=0 |
|
